Literature DB >> 19416081

Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).

Marie-Christine W Gast1, Carla H van Gils, Lodewijk F A Wessels, Nathan Harris, Johannes M G Bonfrer, Emiel J Th Rutgers, Jan H M Schellens, Jos H Beijnen.   

Abstract

BACKGROUND: Issues have been raised concerning the robustness and validity of alleged serum markers discovered by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS). Pre-analytical variables have been shown to exert a profound effect on protein profiles, irrespective of true biological variation. However, little is known about the possible effects of sample storage duration on protein profiles. We, therefore, aimed to investigate the effects of extended storage duration on the serum protein profile.
METHODS: Archival sera from 140 breast cancer patients, stored at -30 degrees C for 1-11 years, were profiled by SELDI-TOF MS using immobilised metal affinity capture (IMAC) arrays, a condition applied in the majority of breast cancer biomarker discovery studies.
RESULTS: Fourteen peak clusters, structurally identified as C3a des-arginine anaphylatoxin and multiple fragments of albumin and fibrinogen, were found to be significantly associated with sample storage duration by five distinct patterns. These proteins have been described previously as potential cancer markers, rendering them specific to both disease and sample handling issues.
CONCLUSIONS: To prevent experimental variation being interpreted erroneously as disease associated variation, assessment of potential confounding pre-analytical parameters is a pre-requisite in biomarker discovery and validation studies. In addition, with respect to the different (non-)linear patterns observed in the current study, simply performing linear corrections to account for sample storage duration will not necessarily suffice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19416081     DOI: 10.1515/CCLM.2009.151

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  15 in total

1.  Search for breast cancer biomarkers in fractionated serum samples by protein profiling with SELDI-TOF MS.

Authors:  Annemieke W J Opstal-van Winden; Jos H Beijnen; Arnoud Loof; Waander L van Heerde; Roel Vermeulen; Petra H M Peeters; Carla H van Gils
Journal:  J Clin Lab Anal       Date:  2012-01       Impact factor: 2.352

Review 2.  Measuring myokines with cardiovascular functions: pre-analytical variables affecting the analytical output.

Authors:  Giovanni Lombardi; Veronica Sansoni; Giuseppe Banfi
Journal:  Ann Transl Med       Date:  2017-08

3.  Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analyses.

Authors:  L Renee Ruhaak; Sandra L Taylor; Suzanne Miyamoto; Karen Kelly; Gary S Leiserowitz; David Gandara; Carlito B Lebrilla; Kyoungmi Kim
Journal:  Anal Bioanal Chem       Date:  2013-03-23       Impact factor: 4.142

Review 4.  Colorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelled.

Authors:  Kim Y C Fung; Edouard Nice; Ilka Priebe; Damien Belobrajdic; Aloke Phatak; Leanne Purins; Bruce Tabor; Celine Pompeia; Trevor Lockett; Timothy E Adams; Antony Burgess; Leah Cosgrove
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

5.  Isothermal vitrification methodology development for non-cryogenic storage of archival human sera.

Authors:  Rebekah Less; Kristin L M Boylan; Amy P N Skubitz; Alptekin Aksan
Journal:  Cryobiology       Date:  2013-01-24       Impact factor: 2.487

6.  Diagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometry.

Authors:  Dongjian Song; Lifang Yue; Junjie Zhang; Shanshan Ma; Wei Zhao; Fei Guo; Yingzhong Fan; Heying Yang; Qiuliang Liu; Da Zhang; Ziqiang Xia; Pan Qin; Jia Jia; Ming Yue; Jiekai Yu; Shu Zheng; Fuquan Yang; Jiaxiang Wang
Journal:  Cancer Biol Ther       Date:  2016-06-03       Impact factor: 4.742

7.  Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach.

Authors:  Daniel Böhm; Ksenia Keller; Julia Pieter; Nils Boehm; Dominik Wolters; Wulf Siggelkow; Antje Lebrecht; Marcus Schmidt; Heinz Kölbl; Norbert Pfeiffer; Franz-Hermann Grus
Journal:  Oncol Rep       Date:  2012-06-01       Impact factor: 3.906

8.  Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study.

Authors:  Annemieke W J Opstal-van Winden; Esmeralda J M Krop; Monica H Kåredal; Marie-Christine W Gast; Christian H Lindh; Marina C Jeppsson; Bo A G Jönsson; Diederick E Grobbee; Petra H M Peeters; Jos H Beijnen; Carla H van Gils; Roel C H Vermeulen
Journal:  BMC Cancer       Date:  2011-08-26       Impact factor: 4.430

9.  Mesoporous silica chip: enabled peptide profiling as an effective platform for controlling bio-sample quality and optimizing handling procedure.

Authors:  Kai Liang; Hongmei Wu; Tony Y Hu; Yan Li
Journal:  Clin Proteomics       Date:  2016-11-22       Impact factor: 3.988

10.  Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry.

Authors:  Dongjian Song; Lifang Yue; Hao Li; Junjie Zhang; Zechen Yan; Yingzhong Fan; Heying Yang; Qiuliang Liu; Da Zhang; Ziqiang Xia; Pan Qin; Jia Jia; Ming Yue; Jiekai Yu; Shu Zheng; Fuquan Yang; Jiaxiang Wang
Journal:  Br J Cancer       Date:  2016-03-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.